Somewhat Favorable Press Coverage Somewhat Unlikely to Affect AmerisourceBergen (ABC) Stock Price

News coverage about AmerisourceBergen (NYSE:ABC) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. AmerisourceBergen earned a news sentiment score of 0.20 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 44.8786720285937 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

These are some of the media headlines that may have effected Accern Sentiment’s scoring:

A number of equities analysts have recently commented on the company. Cowen set a $107.00 price target on AmerisourceBergen and gave the stock a “buy” rating in a report on Tuesday. Robert W. Baird set a $99.00 price target on AmerisourceBergen and gave the stock a “buy” rating in a report on Friday, December 1st. Jefferies Group set a $85.00 price target on AmerisourceBergen and gave the stock a “hold” rating in a report on Sunday, October 29th. Needham & Company LLC raised their price target on AmerisourceBergen from $86.00 to $88.00 and gave the stock a “buy” rating in a report on Wednesday, November 22nd. Finally, Royal Bank of Canada assumed coverage on AmerisourceBergen in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $87.00 price target for the company. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. AmerisourceBergen has an average rating of “Buy” and a consensus price target of $93.20.

Shares of AmerisourceBergen (ABC) traded up $0.66 during mid-day trading on Wednesday, hitting $88.48. The company had a trading volume of 1,391,586 shares, compared to its average volume of 1,790,927. The company has a quick ratio of 0.48, a current ratio of 0.91 and a debt-to-equity ratio of 1.83. AmerisourceBergen has a one year low of $71.90 and a one year high of $97.85. The stock has a market capitalization of $18,922.97, a P/E ratio of 14.73, a PEG ratio of 1.50 and a beta of 1.00.

AmerisourceBergen (NYSE:ABC) last issued its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.32 by $0.01. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. The company had revenue of $39.12 billion for the quarter, compared to the consensus estimate of $40.10 billion. During the same quarter last year, the business posted $1.30 earnings per share. The firm’s revenue was up 4.2% compared to the same quarter last year. sell-side analysts predict that AmerisourceBergen will post 6.07 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 4th. Investors of record on Monday, November 20th were given a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date was Friday, November 17th. This is an increase from AmerisourceBergen’s previous quarterly dividend of $0.37. AmerisourceBergen’s dividend payout ratio (DPR) is 82.16%.

In related news, insider Dale Danilewitz sold 1,857 shares of the stock in a transaction on Monday, November 13th. The stock was sold at an average price of $74.69, for a total value of $138,699.33. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Tim G. Guttman sold 11,600 shares of the stock in a transaction on Wednesday, September 20th. The stock was sold at an average price of $79.47, for a total value of $921,852.00. The disclosure for this sale can be found here. Insiders sold 170,407 shares of company stock worth $13,745,358 in the last quarter. 27.40% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “Somewhat Favorable Press Coverage Somewhat Unlikely to Affect AmerisourceBergen (ABC) Stock Price” was posted by Week Herald and is owned by of Week Herald. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://weekherald.com/2017/12/13/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-amerisourcebergen-abc-stock-price.html.

About AmerisourceBergen

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply